EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The protective effect of DNase I in retinal vein occlusion

Guohua Deng, Xi Zou, Zhinan Liu, Hang Ren, Yanting Li, Bin Chen, Jun Zhang

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2023.9780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Guohua Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China. Hauptthemen laut MEDLINE: Extracellular Traps, Retinal Vein Occlusion. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal vein occlusion (RVO) ranks as the second most prevalent retinal vascular disease, following diabetic retinopathy. Neutrophil extracellular traps (NETs) play an important role in vascular diseases. This study aimed to elucidate the relationship between NETs and RVO, and to discern the potential role of deoxyribonuclease I (DNase I) in the prevention and treatment of RVO through the modulation of NETs. We analyzed circulating NETs biomarkers, namely cell-free DNA (cf-DNA), myeloperoxidase (MPO)-DNA, and neutrophil elastase (NE), in 30 RVO patients and 30 healthy individuals. We established an RVO mouse model using a retinal laser, and the mice were categorized into two groups: the DNase I group and the control group. Retinal images were taken at predetermined time points, and the state of the retinal vessels was assessed. Both tissue and blood samples were harvested for analysis of NETs expression through methods such as western blotting, immunofluorescence staining, and enzyme-linked immunosorbent assay (ELISA). Our finding indicate an increase in circulating NETs biomarkers in human and mouse RVO cases, while also verifying the presence of NETs in the retinal thrombus of the RVO model. Both in vitro and in vivo tests revealed that DNase I attenuated NETs formation. Moreover, DNase I injections led to diminished NETs biomarker levels and a reduced duration of the thrombus after the RVO model establishment. Consequently, DNase I, a well-established modulator of NETs formation, might exhibit protective properties in the prevention and treatment of RVO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular TrapsRetinal Vein OcclusionAnimalsHumansMiceBiomarkersDeoxyribonuclease IDNA

Substanzen

BiomarkersDeoxyribonuclease IDNADNASE1 protein, human

Autor:innen und Institutionen

  • Department of Ophthalmology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, China.
  • Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Ophthalmology, Suzhou Eye and ENT Hospital, Suzhou, China.

Zitieren

APA

Deng, G., Zou, X., Liu, Z., Ren, H., Li, Y., Chen, B., & Zhang, J. (2024). The protective effect of DNase I in retinal vein occlusion. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2023.9780

Vancouver

Deng G, Zou X, Liu Z, Ren H, Li Y, Chen B, et al. The protective effect of DNase I in retinal vein occlusion. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2023.9780

BibTeX
@article{Deng2024,
  author = {Deng, Guohua and Zou, Xi and Liu, Zhinan and Ren, Hang and Li, Yanting and Chen, Bin and Zhang, Jun},
  title = {The protective effect of DNase I in retinal vein occlusion},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2023.9780}
}
Kostenlos starten →